(Reuters) -Pfizer Inc and its German partner BioNTech SE said on Friday they would include and evaluate a third dose of their COVID-19 vaccine in an ongoing trial in children six months to under five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results